Asia Pacific Companion Animal Diagnostics Market Analysis and Forecast by Size, Share, Growth, Trends 2031

The Asia Pacific Companion Animal Diagnostics Market size is expected to reach US$ 1,653.5 Million by 2031 from US$ 840.0 Million in 2024. The market is estimated to record a CAGR of 10.2% from 2025 to 2031.

Executive Summary and Asia Pacific Companion Animal Diagnostics Market Analysis:

The companion animal diagnostics market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Significant players are present in the regional market, with IDEXX and Zoetis holding a considerable market share. Companies actively engage in strategic activities such as new product launches, geographical expansion, and mergers and acquisitions to gain a competitive edge.

As veterinary specialization grows in APAC, pet owners have better access to specialized diagnostic services. They aim to specialize veterinary clinics and specialists who deliver in-depth expertise and advanced diagnostics for specific conditions. The existence of board-certified specialists in APAC enhances the overall quality of care for companion animals. The development of veterinary specialization in APAC has increased educational opportunities for veterinarians seeking specialized training, promoting a culture of continuous learning and expertise.

The awareness of animal health is rising in the Asia Pacific. As awareness grows regarding the importance of preventive care, early disease detection, and timely treatment, companion animal owners increasingly seek reliable diagnostic tests to monitor their animals' health. This innovation appeals to various medical fields, including emergency medicine, nursing, and surgery.

Asia Pacific Companion Animal Diagnostics Market: Strategic Insights

Asia Pacific Companion Animal Diagnostics Market Segmentation Analysis:

• By Product, the Asia Pacific Companion Animal Diagnostics Market is segmented into Consumables and Instruments. Consumables held the largest share of the market in 2024.
• By Companion Animal, the Asia Pacific Companion Animal Diagnostics Market is segmented into Dogs, Cats, Horses, and Others. Dogs held the largest share of the market in 2024.
• By Technology, the Asia Pacific Companion Animal Diagnostics Market is segmented into Immunodiagnostics, Molecular Diagnostics, Clinical Biochemistry, Hematology, Urinalysis, and Others. Immunodiagnostics held the largest share of the market in 2024.
• By Application, the Asia Pacific Companion Animal Diagnostics Market is segmented into Clinical Pathology, Bacteriology, Parasitology, Virology, and Others. Clinical Pathology held the largest share of the market in 2024.
• By End Users, the Asia Pacific Companion Animal Diagnostics Market is segmented into Diagnostic and Reference Laboratories, Veterinary Hospitals and Clinics, Research Institutes, and Others. Veterinary Hospitals and Clinics held the largest share of the market in 2024.

Asia Pacific Companion Animal Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

The Asia Pacific Companion Animal Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Asia Pacific Companion Animal Diagnostics Market Outlook

The humanization of pets is growing, and the global population is reshaping the veterinary healthcare landscape. Pet owners are increasingly willing to pay for their pets' health, boosting the demand for accurate and minimally invasive diagnostic solutions.

Companies of animals are highly prone to infectious and chronic diseases that need an early diagnosis. Several references highlight the growing adoption of dogs and their related expenditure on healthcare services. The pet industry is comprehensive, and the demand for companion animal diagnostic products is expected to increase during the forecast period. According to HealthforAnimals' report, over two million people adopted pets during the UK's pandemic lockdowns, while in Australia, over a million pets were adopted during the pandemic. Moreover, families in the US, EU, and China have adopted more than half a billion dogs and cats. Recently, dogs have been the most popular pets in around one in three homes. Nearly a quarter of pet owners have a cat.Demographic changes, rising income levels, and the COVID-19 pandemic have increased the number of people adopting pets.

Pet owners in well-developed economies seek protection against the escalating veterinary treatment costs by applying for a pet insurance policy. Although the penetration rate of pet ownership in the US and Canada is lower compared to some European countries, its growth trend is progressive and fueled by increased awareness of the significance of pet insurance, coupled with humanization. Owners are much more likely to agree to diagnostic testing despite being unaffordable. This mainly occurs in POC diagnostics, which have the added benefit of delivering rapid results.

It makes pet owners more proactive about preventing health concerns. Routine checkups and the early detection of possible health issues have become standard practice, increasing the demand for veterinary POC diagnostic tools that would be applied during routine visits for early-stage condition detection. Thus, growing pet ownership and their humanization boost the companion animal diagnostics market growth.

Asia Pacific Companion Animal Diagnostics Market Country Insights

By country, the Asia Pacific Companion Animal Diagnostics Market is segmented into China, India, Japan, Australia, South Korea, and the Rest of APAC. China held the largest share in 2024.

China's pet population is growing, leading to increased demand for veterinary services, including diagnostics. The majority of Chinese households have pets, including dogs and cats. Pet owners are also becoming increasingly concerned about the food they feed their animals because some pet meals can lead to health allergies and impair their general health and fitness. According to the Global Pets Data published in February 2023, there were 112.3 million urban dogs in China in 2021, an 11.4% rise from the previous year. In China, dogs aged 1 to 5 years account for 50.3% of all dogs, while older dogs account for 37% and pups for 12.7%.

The market's growth in China is due to increasing government support for research and development activities in veterinary medicine, technological advancements resulting in different market consolidations, and the rising adoption of pet animals. The standards encourage ethically proper animal handling and improve China's prospects for global research collaborations. Thus, government support to enhance animal health will likely aid the companion animal diagnostics market.

The companion animal diagnostics market in China is expected to expand owing to the growing pet population, increasing awareness of pet health, and rising technological advancements. The market offers substantial opportunities for domestic and international players to contribute to the well-being of companion animals in China. In January 2024, Zoetis Inc. expanded its Vetscan Imagyst platform to include AI Urine Sediment analysis. This unique application offers quick and accurate in-clinic sediment analysis of fresh urine, enabling personalized treatment plans for pets. Powered by deep learning AI, it delivers constant results within minutes, supporting veterinarians in providing optimal patient care.
China's companion animal diagnostics market is developing with efforts to reclassify companion animals, raise awareness about animal health and zoonotic diseases, and increase the frequency of animal disease outbreaks. In April 2020, the Ministry of Agriculture and Rural Affairs announced a mandate to reclassify dogs as companion animals instead of livestock.

Asia Pacific Companion Animal Diagnostics Market Company Profiles

Some of the key players operating in the market include Zoetis Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Tianjin LOCMEDT Technologies Co Ltd, ARI Medical Technology Co Ltd, and Demeditec Diagnostics GmbH.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Asia Pacific Companion Animal Diagnostics Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise